Stoichiometric tuning of nucleic acid hybridization probes by auxiliary oligonucleotide species
Inventors
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Assignees
Rice UniversityRice University is a leading research university in Houston, Texas, recognized for its emphasis on scientific discovery, innovation, and interdisciplinary collaboration. The institution is committed to academic excellence, impactful research, and community engagement, offering robust undergraduate and graduate programs in engineering, natural sciences, social sciences, humanities, business, and the arts. Rice is distinguished by its history of collaboration with organizations such as NASA, fostering advances in space science, biotechnology, energy research, and artificial intelligence.
Rice University is a leading research university in Houston, Texas, recognized for its emphasis on scientific discovery, innovation, and interdisciplinary collaboration. The institution is committed to academic excellence, impactful research, and community engagement, offering robust undergraduate and graduate programs in engineering, natural sciences, social sciences, humanities, business, and the arts. Rice is distinguished by its history of collaboration with organizations such as NASA, fostering advances in space science, biotechnology, energy research, and artificial intelligence.
Abstract
This invention describes a method of controlling the hybridization yield of nucleic acid probes by adjusting the relative concentrations of auxiliary oligonucleotides to the probes and the targets. The auxiliary oligonucleotide is partially or fully complementary to either the probe or the target, and is released upon hybridization of the probe to the target.
Core Innovation
This disclosure provides methods for stoichiometric tuning of hybridization probes using competitive auxiliary nucleic acid species, wherein the auxiliary species is either complementary to the target (blockers) or complementary to the probe (protectors). The method controls hybridization yield by adjusting the relative concentrations of the auxiliary oligonucleotide and probe (with the auxiliary present at higher initial concentration), and the auxiliary oligonucleotide is released upon hybridization of the probe to the target. The disclosure provides analytical and experimental approaches for determining the auxiliary concentration that yields a desired proportion of target hybridized to probe.
The invention addresses bias and inaccuracy in hybrid-capture molecular enrichment by providing on-the-fly adjustment of hybridization yield, more predictive and precise control than probe sequence adjustment, and iterative tuning suitable for multiplexed assays and complex target sequences. Two implementations are described: the Protector implementation (probe C pre-hybridized to protector P; reaction PC+T≈TC+P) and the Blocker implementation (probe D and blocker B; reaction D+TB≈TD+B), with methods to compute or infer the auxiliary concentration needed to achieve a desired equilibrium or pre-equilibrium yield.
Claims Coverage
Two independent claims were identified. The following inventive features are extracted from the independent claims and describe the main claimed innovations (three inventive features).
Probe composition comprising two nucleic acid molecules with defined subsequence complementarity
A nucleic acid probe comprising a first nucleic acid molecule that includes a first probe subsequence and a second probe subsequence complementary to adjacent target subsequences, and a second nucleic acid molecule that includes a third probe subsequence complementary to at least a subsequence of the first probe subsequence and not sufficient to hybridize to the second probe subsequence, wherein the second concentration is greater than the first concentration.
Determination of adjusted auxiliary concentration from experimental yield using Equation 1
A method step of determining an experimental yield (proportion of target hybridized to the first nucleic acid molecule) and calculating a third concentration of the second nucleic acid molecule ([P]′0) according to Equation 1 using the initial auxiliary concentration [P]0, the experimental yield χ1, and the desired yield χ2.
Preparing or providing instructions to prepare the probe with the adjusted auxiliary concentration
Providing instructions to use the determined third concentration of the second nucleic acid molecule for preparation of the nucleic acid probe or preparing the nucleic acid probe by combining the first nucleic acid molecule at the first concentration with the second nucleic acid molecule at the third concentration to achieve the desired yield.
The independent claims cover probes composed of two nucleic acid molecules with specified complementary subsequences and a higher auxiliary concentration, methods to determine an adjusted auxiliary concentration based on experimental and desired yields (via Equation 1), and preparing or instructing preparation of probes using the adjusted auxiliary concentration to achieve a specified hybridization yield.
Stated Advantages
On-the-fly adjustment of the hybridization yield.
More predictive and precise control than probe sequence adjustment.
Allows iterative tuning for multiplexed assays and for complex target sequences.
Capture yield can be continuously tuned over a wide range (e.g., essentially 0.01% to 99.9%).
Documented Applications
Selective capture or enrichment of nucleic acid molecules bearing target nucleic acid sequences (general targeted capture/enrichment).
NGS target enrichment assays and targeted sequencing workflows.
Depletion assays where high yield (sensitivity) is desired.
Highly multiplexed applications requiring improved uniform yield of different targets to minimize bias.
SNP discrimination by tuning auxiliary concentration to improve differential yields between single nucleotide variants.
Enrichment of rare or specific sequences in samples (examples in background include circulating tumor cells, cell-free DNA exomes, and sepsis-causing bacteria).
Interested in licensing this patent?
